BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27913677)

  • 1. PHLPPing through history: a decade in the life of PHLPP phosphatases.
    Grzechnik AT; Newton AC
    Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling.
    Warfel NA; Newton AC
    J Biol Chem; 2012 Feb; 287(6):3610-6. PubMed ID: 22144674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turning off AKT: PHLPP as a drug target.
    Newton AC; Trotman LC
    Annu Rev Pharmacol Toxicol; 2014; 54():537-58. PubMed ID: 24392697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
    Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
    Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growth.
    Liu J; Stevens PD; Li X; Schmidt MD; Gao T
    Mol Cell Biol; 2011 Dec; 31(24):4917-27. PubMed ID: 21986499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PHLPPing the Script: Emerging Roles of PHLPP Phosphatases in Cell Signaling.
    Baffi TR; Cohen-Katsenelson K; Newton AC
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():723-743. PubMed ID: 32997603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHLiPPing the switch on Akt and protein kinase C signaling.
    Brognard J; Newton AC
    Trends Endocrinol Metab; 2008 Aug; 19(6):223-30. PubMed ID: 18511290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phosphatase PHLPP controls the cellular levels of protein kinase C.
    Gao T; Brognard J; Newton AC
    J Biol Chem; 2008 Mar; 283(10):6300-11. PubMed ID: 18162466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms.
    Brognard J; Sierecki E; Gao T; Newton AC
    Mol Cell; 2007 Mar; 25(6):917-31. PubMed ID: 17386267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of survival signalling pathways by the phosphatase PHLPP.
    O'Neill AK; Niederst MJ; Newton AC
    FEBS J; 2013 Jan; 280(2):572-83. PubMed ID: 22340730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoreceptor Neuroprotection: Regulation of Akt Activation Through Serine/Threonine Phosphatases, PHLPP and PHLPPL.
    Rajala RV; Kanan Y; Anderson RE
    Adv Exp Med Biol; 2016; 854():419-24. PubMed ID: 26427440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical characterization of the phosphatase domain of the tumor suppressor PH domain leucine-rich repeat protein phosphatase.
    Sierecki E; Newton AC
    Biochemistry; 2014 Jun; 53(24):3971-81. PubMed ID: 24892992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of PHLPP1 and PHLPP2 correlates with poor prognosis in patients with hypopharyngeal squamous cell carcinoma.
    Zhou J; Yu X; Wang J; Li T; Jin T; Lei D; Pan X
    PLoS One; 2015; 10(3):e0119405. PubMed ID: 25793736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation.
    Nitsche C; Edderkaoui M; Moore RM; Eibl G; Kasahara N; Treger J; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS
    Gastroenterology; 2012 Feb; 142(2):377-87.e1-5. PubMed ID: 22044669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WD repeat protein WDR48 in complex with deubiquitinase USP12 suppresses Akt-dependent cell survival signaling by stabilizing PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1).
    Gangula NR; Maddika S
    J Biol Chem; 2013 Nov; 288(48):34545-54. PubMed ID: 24145035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleckstrin Homology (PH) Domain Leucine-rich Repeat Protein Phosphatase Controls Cell Polarity by Negatively Regulating the Activity of Atypical Protein Kinase C.
    Xiong X; Li X; Wen YA; Gao T
    J Biol Chem; 2016 Nov; 291(48):25167-25178. PubMed ID: 27760826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes.
    Jackson TC; Verrier JD; Drabek T; Janesko-Feldman K; Gillespie DG; Uray T; Dezfulian C; Clark RS; Bayir H; Jackson EK; Kochanek PM
    J Pharmacol Exp Ther; 2013 Nov; 347(2):516-28. PubMed ID: 24023368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance.
    Andreozzi F; Procopio C; Greco A; Mannino GC; Miele C; Raciti GA; Iadicicco C; Beguinot F; Pontiroli AE; Hribal ML; Folli F; Sesti G
    Diabetologia; 2011 Jul; 54(7):1879-87. PubMed ID: 21461637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis.
    Liu J; Weiss HL; Rychahou P; Jackson LN; Evers BM; Gao T
    Oncogene; 2009 Feb; 28(7):994-1004. PubMed ID: 19079341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer.
    Li X; Stevens PD; Yang H; Gulhati P; Wang W; Evers BM; Gao T
    Oncogene; 2013 Jan; 32(4):471-8. PubMed ID: 22391563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.